Sato Kazutoshi, Itoh Takehiro, Kato Toshiki, Kitamura Yukiko, Kaul Sunil C, Wadhwa Renu, Sato Fujio, Ohneda Osamu
Department of Regenerative Medicine and Stem Cell Biology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305 8575, Japan,
In Vitro Cell Dev Biol Anim. 2015 May;51(5):515-29. doi: 10.1007/s11626-014-9860-0. Epub 2015 Jan 15.
Cell therapy using human mesenchymal stem cells (MSCs) is an attractive approach for many refractory diseases. Adipose tissue-derived mesenchymal stem cells (AT-MSCs) are considered as a favorable tool due to its abundance in the body, easy proliferation, and high cytokine production potency. In order to avoid the risks associated with the use of fetal bovine serum (FBS) in culture that includes batch variations and contamination with pathogens, development of serum-free culture system has been initiated. We have formulated a completely serum-free culture medium (SFM) that could be used not only for the expansion of AT-MSCs but also for initial isolation. We demonstrate that the AT-MSCs isolated and cultured in serum-free medium (AT-MSCs/SFM) possess high proliferation capacity and differentiation potency to osteoblast, adipocyte, and chondrocyte lineages in vitro. In in vivo bone fraction model analysis, AT-MSCs/SFM showed higher bone repair potency and quality of the regenerated bone than the cells cultured in serum-containing medium (AT-MSCs/SCM). This was attributed to the (i) presence of translated cells in the bone, as evidenced by in vivo imaging of the illuminated translated cells and (ii) high level of expression and induction capacity of AT-MSCs/SFM for cytokine BMP2, CCL2, and CCL5. Taken together, we report a new serum-free culture system for AT-MSCs that is suitable for cell therapy.
使用人间充质干细胞(MSCs)进行细胞治疗是治疗许多难治性疾病的一种有吸引力的方法。脂肪组织来源的间充质干细胞(AT-MSCs)因其在体内含量丰富、易于增殖以及细胞因子产生能力高而被视为一种有利的工具。为了避免在培养中使用胎牛血清(FBS)带来的风险,包括批次差异和病原体污染,人们已开始研发无血清培养系统。我们配制了一种完全无血清培养基(SFM),它不仅可用于AT-MSCs的扩增,还可用于初始分离。我们证明,在无血清培养基中分离和培养的AT-MSCs(AT-MSCs/SFM)在体外对成骨细胞、脂肪细胞和软骨细胞谱系具有高增殖能力和分化潜能。在体内骨碎片模型分析中,与在含血清培养基中培养的细胞(AT-MSCs/SCM)相比,AT-MSCs/SFM显示出更高的骨修复能力和再生骨质量。这归因于:(i)骨中存在转染细胞,这通过对经光照的转染细胞的体内成像得以证明;(ii)AT-MSCs/SFM对细胞因子BMP2、CCL2和CCL5具有高水平的表达和诱导能力。综上所述,我们报告了一种适用于细胞治疗的新型AT-MSCs无血清培养系统。